- Cellectis complète l’annonce des modalités définitives de son offre d’ADS avec la répartition de son capital après la réalisation de son offre d’ADS
- Cellectis Supplements the Announcement of the Pricing of Follow-On Offering with Allocation of Share Capital Information
- Cellectis annonce les modalités définitives de son offre d’ADS
- Cellectis Announces Pricing of Follow-On Offering
- Cellectis Announces Launch of Follow-On Offering
- Cellectis annonce le lancement d’une nouvelle offre d’ADS
- Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
- Cellectis modifie sa note convertible de 20 millions de dollars dans le cadre de l’accord de collaboration avec son partenaire Cytovia Therapeutics
- Calyxt et Cibus annoncent la signature d’un Accord de Fusion
- Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement
More ▼
Key statistics
On Friday, Cellectis SA (ALCLS:DEU) closed at 2.38, 45.07% above the 52 week low of 1.64 set on Dec 29, 2022.
52-week range
Markit short selling activity
Open | 2.45 |
---|---|
High | 2.52 |
Low | 2.30 |
Bid | 2.44 |
Offer | 2.48 |
Previous close | 2.99 |
Average volume | 402.64 |
---|---|
Shares outstanding | 45.68m |
Free float | 45.57m |
P/E (TTM) | -- |
Market cap | 109.89m EUR |
EPS (TTM) | -2.12 EUR |
Data delayed at least 15 minutes, as of Feb 03 2023 16:56 GMT.
More ▼